SPY389.63+0.17 0.04%
DIA312.42-0.01 0.00%
IXIC11,354.62-33.88 -0.30%

--BMO Capital Adjusts Alnylam Pharmaceuticals Price Target to $166 From $171, Maintains Market Perform Rating

MT Newswires · 04/29/2022 09:07

Please log in to view news